AtaiBeckley (ATAI) Other Non Operating Income (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Other Non Operating Income of -$409000.0 in Q1 2026, down 189.69% quarter-over-quarter from $456000.0 in Q1 2025, and down 189.69% on a YoY basis from $456000.0 in Q1 2025.
AtaiBeckley (ATAI) Other Non Operating Income (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Other Non Operating Income across 6 years of filings, most recently posting -$752000.0 for Q2 2025.
- Other Non Operating Income for Q2 2025 came in at -$752000.0, down 716.39% year-over-year; the trailing twelve-month figure through Sep 2025 was -$2.0 million (down 1001.09% YoY), and the FY2024 annual result was -$1.3 million, down 568.25% from the prior year.
- Other Non Operating Income was -$409000.0 for Q1 2026 at AtaiBeckley, down from $456000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $456000.0 in Q1 2025 to a low of -$409000.0 in Q1 2026.
- The 5-year median for Other Non Operating Income is -$61500.0 (2023), against an average of $491714.3.
- Peak annual rise in Other Non Operating Income reached 58845.45% in 2021, while the deepest fall reached 1392.57% in 2021.
- AtaiBeckley's Other Non Operating Income stood at -$5.7 million in 2021, then jumped by 222.22% to $7.0 million in 2022, then slumped by 101.27% to -$89000.0 in 2023, then sank by 1319.1% to -$1.3 million in 2024, then jumped by 40.46% to -$752000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$752000.0 (Q2 2025), -$1.3 million (Q4 2024), and $122000.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -409,000.00 |
| Jun 30, 2025 | -752,000.00 |
| Mar 31, 2025 | 456,000.00 |
| Dec 31, 2024 | -1.26 Mn |
| Jun 30, 2024 | 122,000.00 |
| Mar 31, 2024 | -216,000.00 |
| Dec 31, 2023 | -89,000.00 |
| Sep 30, 2023 | -308,000.00 |
| Jun 30, 2023 | -34,000.00 |
| Mar 31, 2023 | 243,000.00 |
| Dec 31, 2022 | 7.01 Mn |
| Sep 30, 2022 | -100,000.00 |
| Jun 30, 2022 | 53,000.00 |
| Dec 31, 2021 | -5.74 Mn |
| Sep 30, 2021 | 6.46 Mn |
| Mar 31, 2021 | 1.49 Mn |
| Dec 31, 2020 | 444,000.00 |
| Sep 30, 2020 | -11,000.00 |
| Jun 30, 2020 | -37,000.00 |